Welcome to our dedicated page for Health In Tech SEC filings (Ticker: HIT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Health In Tech, Inc. filings document material-event disclosures for a Nevada operating company with Class A common stock listed on the Nasdaq Capital Market under HIT. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD materials, investor presentations and conference-call transcripts.
The filing record also addresses capital-structure matters, including a private investment in public equity financing, and governance disclosures involving executive officer departures, compensatory arrangements and related consulting agreements. The company identifies as an emerging growth company in its Exchange Act reports.
McStravock John reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. reported that General Counsel John McStravock received a grant of 5,000 restricted shares of Class A Common Stock as equity compensation. These shares were granted at no cash cost to him.
The restricted shares will vest in equal monthly installments over a twelve-month period starting on April 6, 2026, as long as he continues to serve with the company through each vesting date. After this grant, he holds 5,000 Class A shares directly.
Health In Tech, Inc. filed an initial insider ownership report for its General Counsel, John McStravock. This Form 3 lists him as an officer but shows no reported stock transactions or derivative positions and no holding entries at the time of this filing.
Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as compensation under the Health in Tech Equity Incentive Plan. The restricted stock vested on the grant date, bringing his direct holdings to 82,333 shares.
Howard William D. reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Howard William D. received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as equity compensation under the Health in Tech Equity Incentive Plan. The restricted shares vested as of the grant date, and he now directly holds a total of 119,643 Class A Common shares.
Hayes Timothy reported acquisition or exercise transactions in this Form 4 filing.
Health In Tech, Inc. director Timothy Hayes received a grant of 13,598 restricted shares of Class A Common Stock on April 8, 2026 under the Health in Tech Equity Incentive Plan. The filing reports the transaction at $1.36 per share.
The footnote states these restricted shares vested as of the grant date, meaning they became fully owned immediately. Following this equity award, Hayes directly holds 119,643 shares of Class A Common Stock.
Health In Tech, Inc. furnished an investor presentation describing its AI-powered marketplace that helps small and mid-sized businesses access self-funded health plans without taking plan or underwriting risk. The company reported 2025 revenue of $33.3M, up from $19.5M in 2024, and 2025 adjusted EBITDA of $4.1M versus $2.3M a year earlier. As of December 31, 2025, it had 22,515 enrolled employees, 795 business clients, and 858 brokers and agencies, with stockholders’ equity of $17.1M. The presentation reiterates 2026 revenue guidance of $45M–$50M, highlights a fee-based model with no claims exposure, and emphasizes plans to drive growth through more brokers, products, and carrier relationships.
Health In Tech, Inc. completed a private investment in public equity financing, raising gross proceeds of approximately $7.0 million. The company issued 5,600,000 shares of common stock at $1.25 per share to institutional and accredited investors in a private placement.
Management states that the additional capital is intended to support the next phase of its AI-enabled InsurTech platform development, fund key technology initiatives, and bring new product capabilities to market. The financing also brings new long-term institutional investors into the shareholder base, which leadership believes can enhance market visibility and support its broader capital markets strategy.
Health In Tech, Inc. entered into a securities purchase agreement for a private investment in public equity (PIPE) covering 5,600,000 common shares at $1.25 per share, for expected gross proceeds of about $7.0 million before fees and expenses.
The company plans to use net proceeds to expand sales distribution, advance technology development, support new product development, and for general corporate purposes and working capital. The PIPE is expected to close on or about March 27, 2026, and the investors will receive resale registration rights for the shares.
Health In Tech, Inc. is an AI-enabled insurance technology company that runs a marketplace for self-funded employer health plans and stop-loss insurance. Its core eDIYBS platform lets brokers upload census data and generate medically underwritten, bindable quotes, often in about two minutes, using third-party AI models and proprietary risk scoring.
The business is vertically integrated through three subsidiaries: SMR (program design and plan management), ICE (MGU underwriting and SaaS quoting), and HI Card (a digital health and claims platform with a 50‑state Medicare-based provider network). For 2025, SMR and ICE contributed 79.4% and 20.6% of revenue, with HI Card at 0.0%.
As of December 31, 2025, the company worked with 583 brokers, 12 TPAs and 263 agencies in 40 states, serving 795 employer clients and 22,515 covered employees. Management reports maintaining profitability while revenue grew 71% year over year from 2024 to 2025. Key risks include dependence on carriers and distribution partners, heavy reliance on third-party AI data vendors, complex regulation of health data and insurance services, cybersecurity and privacy exposure, and execution challenges as the company scales its platform and enters new product lines and markets.
Health In Tech, Inc. reported strong growth for 2025, with total revenue of $33.3 million and net income of $1.28 million, as the business scaled its AI-enabled InsurTech platform. Management highlighted that full-year revenue grew 71% year over year.
The company issued an upbeat 2026 outlook, guiding for revenue between $45 million and $50 million, implying approximately 35%–50% growth driven by expanding use of its underwriting marketplace and new features launched in January 2026. Adjusted EBITDA for 2025 was $4.11 million, and cash and cash equivalents were $7.67 million as of December 31, 2025.